Product References
Regulation of Hypoxic-Adenosinergic Signaling by Estrogen: Implications for Microvascular Injury.
Pharmaceuticals (Basel, Switzerland)
Cassavaugh J,Qureshi N,Csizmadia E,Longhi MS,Matyal R,Robson SC
Fri Mar 10 00:00:00 EST 2023
Abrogation of ARF6 in promoting erastin-induced ferroptosis and mitigating capecitabine resistance in gastric cancer cells.
Journal of gastrointestinal oncology
Geng D,Wu H
Wed Jun 01 00:00:00 EDT 2022
Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma.
Cancer cell international
Sun Q,Xu W,Ji S,Qin Y,Liu W,Hu Q,Zhang Z,Liu M,Yu X,Xu X
Fri Apr 08 00:00:00 EDT 2022
Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma.
Cancer cell international
Sun Q,Xu W,Ji S,Qin Y,Liu W,Hu Q,Zhang Z,Liu M,Yu X,Xu X
Fri Apr 08 00:00:00 EDT 2022
RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin.
Journal of clinical medicine
Chun JW,Lee B,Park WS,Han N,Hong EK,Park EY,Han SS,Park SJ,Kim TH,Lee WJ,Woo SM
Mon Oct 11 00:00:00 EDT 2021
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy.
Cell
Koikawa K,Kibe S,Suizu F,Sekino N,Kim N,Manz TD,Pinch BJ,Akshinthala D,Verma A,Gaglia G,Nezu Y,Ke S,Qiu C,Ohuchida K,Oda Y,Lee TH,Wegiel B,Clohessy JG,London N,Santagata S,Wulf GM,Hidalgo M,Muthuswamy SK,Nakamura M,Gray NS,Zhou XZ,Lu KP
Thu Sep 02 00:00:00 EDT 2021
The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.
Theranostics
Chen L,Wang Z,Xu Q,Liu Y,Chen L,Guo S,Wang H,Zeng K,Liu J,Zeng S,Yu L
Wed Apr 07 00:00:00 EDT 2021
The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.
Theranostics
Chen L,Wang Z,Xu Q,Liu Y,Chen L,Guo S,Wang H,Zeng K,Liu J,Zeng S,Yu L
Wed Apr 07 00:00:00 EDT 2021
Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells.
American journal of cancer research
Ye Z,Hu Q,Zhuo Q,Zhu Y,Fan G,Liu M,Sun Q,Zhang Z,Liu W,Xu W,Ji S,Yu X,Xu X,Qin Y
Mon Sep 28 00:00:00 EDT 2020
ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
Gastroenterology
Liu M,Zhang Y,Yang J,Cui X,Zhou Z,Zhan H,Ding K,Tian X,Yang Z,Fung KA,Edil BH,Postier RG,Bronze MS,Fernandez-Zapico ME,Stemmler MP,Brabletz T,Li YP,Houchen CW,Li M
Sat Feb 01 00:00:00 EST 2020
Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Dai S,Peng Y,Zhu Y,Xu D,Zhu F,Xu W,Chen Q,Zhu X,Liu T,Hou C,Wu J,Miao Y
Wed Jan 01 00:00:00 EST 2020
Predictive and Prognostic Properties of Human Equilibrative Nucleoside Transporter 1 Expression in Gemcitabine-Treated Pancreatobiliary Cancer: A Meta-Analysis.
JCO precision oncology
Vos LJ,Yusuf D,Lui A,Abdelaziz Z,Ghosh S,Spratlin JL,Mackey JR
Sun Dec 01 00:00:00 EST 2019
Roles of organic anion transporter 2 and equilibrative nucleoside transporter 1 in hepatic disposition and antiviral activity of entecavir during non-pregnancy and pregnancy.
British journal of pharmacology
Ma Z,Lu S,Sun D,Bai M,Jiang T,Lin N,Zhou H,Zeng S,Jiang H
Sun Sep 01 00:00:00 EDT 2019
Correlation of 4'-[methyl-11C]-thiothymidine uptake with human equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in patients with newly diagnosed gliomas.
Annals of nuclear medicine
Takami Y,Yamamoto Y,Ueno M,Chiba Y,Norikane T,Hatakeyama T,Miyake K,Toyohara J,Nishiyama Y
Thu Nov 01 00:00:00 EDT 2018
Correlation of 4'-[methyl-11C]-thiothymidine uptake with human equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in patients with newly diagnosed gliomas.
Annals of nuclear medicine
Takami Y,Yamamoto Y,Ueno M,Chiba Y,Norikane T,Hatakeyama T,Miyake K,Toyohara J,Nishiyama Y
Thu Nov 01 00:00:00 EDT 2018
Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling.
Oncogene
Meng Q,Shi S,Liang C,Liang D,Hua J,Zhang B,Xu J,Yu X
Thu Nov 01 00:00:00 EDT 2018
Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling.
Oncogene
Meng Q,Shi S,Liang C,Liang D,Hua J,Zhang B,Xu J,Yu X
Thu Nov 01 00:00:00 EDT 2018
Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling.
Oncogene
Meng Q,Shi S,Liang C,Liang D,Hua J,Zhang B,Xu J,Yu X
Thu Nov 01 00:00:00 EDT 2018
Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling.
Oncogene
Meng Q,Shi S,Liang C,Liang D,Hua J,Zhang B,Xu J,Yu X
Thu Nov 01 00:00:00 EDT 2018
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.
BMC cancer
Freiburghaus C,Emruli VK,Johansson A,Eskelund CW,Grønbæk K,Olsson R,Ek F,Jerkeman M,Ek S
Wed Apr 25 00:00:00 EDT 2018
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.
BMC cancer
Freiburghaus C,Emruli VK,Johansson A,Eskelund CW,Grønbæk K,Olsson R,Ek F,Jerkeman M,Ek S
Wed Apr 25 00:00:00 EDT 2018
ATP metabolizing enzymes ENPP1, 2 and 3 are localized in sensory neurons of rat dorsal root ganglion.
European journal of histochemistry : EJH
Nishida K,Nomura Y,Kawamori K,Ohishi A,Nagasawa K
Mon Apr 09 00:00:00 EDT 2018
DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study.
Oncotarget
Woo SM,Yoon KA,Hong EK,Park WS,Han SS,Park SJ,Joo J,Park EY,Lee JH,Kim YH,Kim TH,Lee WJ
Fri Oct 06 00:00:00 EDT 2017
FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.
Oncology reports
Hu Q,Qin Y,Zhang B,Liang C,Ji S,Shi S,Xu W,Xiang J,Liang D,Ni Q,Yu X,Xu J
Sun Oct 01 00:00:00 EDT 2017
FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.
Oncology reports
Hu Q,Qin Y,Zhang B,Liang C,Ji S,Shi S,Xu W,Xiang J,Liang D,Ni Q,Yu X,Xu J
Sun Oct 01 00:00:00 EDT 2017
FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.
Oncology reports
Hu Q,Qin Y,Zhang B,Liang C,Ji S,Shi S,Xu W,Xiang J,Liang D,Ni Q,Yu X,Xu J
Sun Oct 01 00:00:00 EDT 2017
FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.
Oncology reports
Hu Q,Qin Y,Zhang B,Liang C,Ji S,Shi S,Xu W,Xiang J,Liang D,Ni Q,Yu X,Xu J
Sun Oct 01 00:00:00 EDT 2017
Deficient Insulin-mediated Upregulation of the Equilibrative Nucleoside Transporter 2 Contributes to Chronically Increased Adenosine in Diabetic Glomerulopathy.
Scientific reports
Alarcón S,Garrido W,Vega G,Cappelli C,Suárez R,Oyarzún C,Quezada C,San Martín R
Fri Aug 25 00:00:00 EDT 2017
Deficient Insulin-mediated Upregulation of the Equilibrative Nucleoside Transporter 2 Contributes to Chronically Increased Adenosine in Diabetic Glomerulopathy.
Scientific reports
Alarcón S,Garrido W,Vega G,Cappelli C,Suárez R,Oyarzún C,Quezada C,San Martín R
Fri Aug 25 00:00:00 EDT 2017
Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy.
PloS one
Kretschmar C,Oyarzún C,Villablanca C,Jaramillo C,Alarcón S,Perez G,Díaz-Encarnación MM,Pastor-Anglada M,Garrido W,Quezada C,San Martín R
Fri Jul 08 00:00:00 EDT 2016
Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy.
PloS one
Kretschmar C,Oyarzún C,Villablanca C,Jaramillo C,Alarcón S,Perez G,Díaz-Encarnación MM,Pastor-Anglada M,Garrido W,Quezada C,San Martín R
Fri Jul 08 00:00:00 EDT 2016
Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy.
PloS one
Kretschmar C,Oyarzún C,Villablanca C,Jaramillo C,Alarcón S,Perez G,Díaz-Encarnación MM,Pastor-Anglada M,Garrido W,Quezada C,San Martín R
Fri Jul 08 00:00:00 EDT 2016
Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy.
PloS one
Kretschmar C,Oyarzún C,Villablanca C,Jaramillo C,Alarcón S,Perez G,Díaz-Encarnación MM,Pastor-Anglada M,Garrido W,Quezada C,San Martín R
Fri Jul 08 00:00:00 EDT 2016
p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines.
Cancer research and treatment
Moon SU,Kim JW,Sung JH,Kang MH,Kim SH,Chang H,Lee JO,Kim YJ,Lee KW,Kim JH,Bang SM,Lee JS
Wed Jul 01 00:00:00 EDT 2015
p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines.
Cancer research and treatment
Moon SU,Kim JW,Sung JH,Kang MH,Kim SH,Chang H,Lee JO,Kim YJ,Lee KW,Kim JH,Bang SM,Lee JS
Wed Jul 01 00:00:00 EDT 2015
The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.
Molecular pharmacology
Hummel-Eisenbeiss J,Hascher A,Hals PA,Sandvold ML,Müller-Tidow C,Lyko F,Rius M
Sun Sep 01 00:00:00 EDT 2013
The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.
Molecular pharmacology
Hummel-Eisenbeiss J,Hascher A,Hals PA,Sandvold ML,Müller-Tidow C,Lyko F,Rius M
Sun Sep 01 00:00:00 EDT 2013
Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone.
World journal of surgical oncology
Murata A,Amano R,Yamada N,Kimura K,Yashiro M,Nakata B,Hirakawa K
Mon May 27 00:00:00 EDT 2013
Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone.
World journal of surgical oncology
Murata A,Amano R,Yamada N,Kimura K,Yashiro M,Nakata B,Hirakawa K
Mon May 27 00:00:00 EDT 2013
Expression of equilibrative nucleoside transporter 1 in rat circumvallate papillae.
Neuroscience letters
Nishida K,Kitada T,Kato J,Dohi Y,Nagasawa K
Tue Jan 15 00:00:00 EST 2013
Expression of equilibrative nucleoside transporter 1 in rat circumvallate papillae.
Neuroscience letters
Nishida K,Kitada T,Kato J,Dohi Y,Nagasawa K
Tue Jan 15 00:00:00 EST 2013
Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine.
Journal of hepato-biliary-pancreatic sciences
Kawada N,Uehara H,Katayama K,Nakamura S,Takahashi H,Ohigashi H,Ishikawa O,Nagata S,Tomita Y
Thu Nov 01 00:00:00 EDT 2012
Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine.
Journal of hepato-biliary-pancreatic sciences
Kawada N,Uehara H,Katayama K,Nakamura S,Takahashi H,Ohigashi H,Ishikawa O,Nagata S,Tomita Y
Thu Nov 01 00:00:00 EDT 2012
The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy.
BJU international
Matsumura N,Nakamura Y,Kohjimoto Y,Inagaki T,Nanpo Y,Yasuoka H,Ohashi Y,Hara I
Fri Jul 01 00:00:00 EDT 2011
The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy.
BJU international
Matsumura N,Nakamura Y,Kohjimoto Y,Inagaki T,Nanpo Y,Yasuoka H,Ohashi Y,Hara I
Fri Jul 01 00:00:00 EDT 2011
Peroxynitrite treatment reduces adenosine uptake via the equilibrative nucleoside transporter in rat astrocytes.
Neuroscience letters
Tanaka A,Nishida K,Okuda H,Nishiura T,Higashi Y,Fujimoto S,Nagasawa K
Fri Jul 01 00:00:00 EDT 2011
Peroxynitrite treatment reduces adenosine uptake via the equilibrative nucleoside transporter in rat astrocytes.
Neuroscience letters
Tanaka A,Nishida K,Okuda H,Nishiura T,Higashi Y,Fujimoto S,Nagasawa K
Fri Jul 01 00:00:00 EDT 2011
Peroxynitrite treatment reduces adenosine uptake via the equilibrative nucleoside transporter in rat astrocytes.
Neuroscience letters
Tanaka A,Nishida K,Okuda H,Nishiura T,Higashi Y,Fujimoto S,Nagasawa K
Fri Jul 01 00:00:00 EDT 2011
Peroxynitrite treatment reduces adenosine uptake via the equilibrative nucleoside transporter in rat astrocytes.
Neuroscience letters
Tanaka A,Nishida K,Okuda H,Nishiura T,Higashi Y,Fujimoto S,Nagasawa K
Fri Jul 01 00:00:00 EDT 2011
Contribution of P2X7 receptors to adenosine uptake by cultured mouse astrocytes.
Glia
Okuda H,Higashi Y,Nishida K,Fujimoto S,Nagasawa K
Mon Nov 01 00:00:00 EDT 2010
Contribution of P2X7 receptors to adenosine uptake by cultured mouse astrocytes.
Glia
Okuda H,Higashi Y,Nishida K,Fujimoto S,Nagasawa K
Mon Nov 01 00:00:00 EDT 2010
Contribution of thymidylate synthase to gemcitabine therapy for advanced pancreatic cancer.
Pancreas
Komori S,Osada S,Mori R,Matsui S,Sanada Y,Tomita H,Tokuyama Y,Takahashi T,Yamaguchi K,Yoshida K
Mon Nov 01 00:00:00 EDT 2010
Contribution of thymidylate synthase to gemcitabine therapy for advanced pancreatic cancer.
Pancreas
Komori S,Osada S,Mori R,Matsui S,Sanada Y,Tomita H,Tokuyama Y,Takahashi T,Yamaguchi K,Yoshida K
Mon Nov 01 00:00:00 EDT 2010